Q4 2023 Holdings
Filed 2024-02-14 | 170 holdings | $279.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY)Put | COM | 02043Q107 | $43.8M | 228,600 | 15.6% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $37.1M | 1,321,834 | 13.3% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $27.4M | 688,316 | 9.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $14.1M | 1,256,591 | 5.0% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $8.7M | 3,468,824 | 3.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.7M | 92,082 | 2.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $7.5M | 185,137 | 2.7% |
| Merrimack Pharmaceuticals in(MACKEUR) | COM NEW | 590328209 | $7.4M | 549,418 | 2.6% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $6.3M | 108,000 | 2.3% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $6.1M | 73,200 | 2.2% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.9M | 54,000 | 2.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $5.8M | 45,884 | 2.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $5.7M | 134,125 | 2.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $4.7M | 254,151 | 1.7% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $4.7M | 110,700 | 1.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.6M | 200,859 | 1.6% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $4.3M | 637,405 | 1.5% |
| Cellectar Biosciences Inc(CLRBUSD) | COM NEW | 15117F807 | $3.8M | 1,378,082 | 1.4% |
| Karuna Therapeutics Inc | COM | 48576A100 | $3.2M | 10,000 | 1.1% |
| Omniab Inc(OABI) | COM | 68218J103 | $3.0M | 478,171 | 1.1% |
| Alteryx Inc(AYXEUR) | COM CL A | 02156B103 | $2.9M | 62,038 | 1.0% |
| Spdr SER TR(BIL) | BLOOMBERG 1-3 MO | 78468R663 | $2.9M | 32,000 | 1.0% |
| Wisdomtree TR(USFR) | FLOATNG RAT TREA | 97717Y527 | $2.8M | 56,000 | 1.0% |
| Corteva Inc(CTVA) | COM | 22052L104 | $2.8M | 58,000 | 1.0% |
| Ishares TR(SHV) | SHORT TREAS BD | 464288679 | $2.7M | 24,500 | 1.0% |
| Vanguard BD Index FDS(VUSB) | VANGUARD ULTRA | 92203C303 | $2.5M | 50,206 | 0.9% |
| SSgA Active ETF TR(ULST) | ULT SHT TRM BD | 78467V707 | $2.5M | 61,264 | 0.9% |
| J P Morgan Exchange Traded F(JPST) | ULTRA SHRT INC | 46641Q837 | $2.5M | 49,000 | 0.9% |
| Cerevel Therapeutics Hldng I(CERE1EUR)Put | COM | 15678U128 | $2.1M | 50,200 | 0.8% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $1.9M | 64,355 | 0.7% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $1.8M | 105,000 | 0.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $1.8M | 9,500 | 0.6% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $1.8M | 8,000 | 0.6% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $1.6M | 1,067,711 | 0.6% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $1.6M | 185,894 | 0.6% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $1.5M | 191,251 | 0.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $1.4M | 74,825 | 0.5% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $1.3M | 245,502 | 0.5% |
| Pfizer Inc(PFE)Call | COM | 717081103 | $1.2M | 43,000 | 0.4% |
| Ishares TR(SHY) | 1 3 YR TREAS BD | 464287457 | $1.2M | 15,000 | 0.4% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $1.2M | 111,326 | 0.4% |
| Kenvue Inc(KVUE) | COM | 49177J102 | $1.1M | 53,293 | 0.4% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $1.1M | 77,558 | 0.4% |
| Orchard Therapeutics PLC | SPON ADS NEW | 68570P200 | $1.0M | 63,622 | 0.4% |
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $1.0M | 132,962 | 0.4% |
| Bicycle Therapeutics PLC(BCYC)Put | SPONSORED ADS | 088786108 | $978.1K | 54,100 | 0.3% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $962.2K | 231,302 | 0.3% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $888.3K | 275,000 | 0.3% |
| Global Star Acquisition Inc | CLASS A COM | 37962G102 | $848.0K | 80,000 | 0.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $777.4K | 8,062 | 0.3% |